Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy - Beck, Laurence H.; Fervenza, Fernando C.; Beck, David M.; Bonegio, Ramon G.B.; Malik, Fahim A.; Erickson, Stephen B.; Cosio, Fernando G.; Cattran, Daniel C.; Salant, David J. (Journal of the American Society of Nephrology, 2011)
Keywords: Adult; Antibodies, Monoclonal - chemistry; Antibodies, Monoclonal, Murine-Derived - pharmacology; Autoantibodies - chemistry; Biological and medical sciences; Biopsy; Clinical Research; Cohort Studies; Female; Glomerulonephritis; Glomerulonephritis, Membranous - drug therapy; Glomerulonephritis, Membranous - immunology; Humans; Immunologic Factors - pharmacology; Male; Medical sciences; Middle Aged; Nephrology. Urinary tract diseases; Nephropathies. Renovascular diseases. Renal failure; Receptors, Phospholipase A2 - chemistry; Receptors, Phospholipase A2 - immunology; Rituximab; Time Factors; Treatment Outcome; Kidney disease; Antineoplastic agent; Autoimmunity; Nephrology; Urinary system disease; Autoantibody; Rituximab; Monoclonal antibody; Urology; Immunomodulator; Depletion; Treatment; Immunotherapy; Membranous glomerulonephritis; Immunosuppressive agent; Predictive factor